RxDoctor Payments Data

Julie Ratliff

Nurse Practitioner · Lafayette, LANPI 1477524510

Payments from drug & device makers

$2,329in general payments, 2019–2025

Across 123 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$698
  • Calliditas Therapeutics US Inc.$205
  • Mallinckrodt Hospital Products Inc.$178
  • Amgen$156
  • ANI Pharmaceuticals, Inc.$128
  • Astellas Pharma US Inc$122
  • plus $842 from 23 others

What the payments were for

  • Food & beverage$2,329100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,329 in reported general payments places this provider in the 80th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide52$55,406
JardianceEmpagliflozin44$49,895
OzempicSemaglutide35$39,372
TradjentaLinagliptin34$25,230
JanuviaSitagliptin Phosphate16$13,959
EliquisApixaban17$11,077
LinzessLinaclotide20$10,564
Spiriva RespimatTiotropium Bromide12$8,043
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,510
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,253
BreynaBudesonide/Formoterol Fumarate14$2,183
Gabapentin96$1,400
Albuterol Sulfate HfaAlbuterol Sulfate55$1,202
Armour ThyroidThyroid,pork28$1,187
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Stiolto Respimat$16$88,678102 claims
Lilly USA, LLCMounjaro$117$55,40652 claims
Novo NordiskOzempic$14$39,37235 claims
AbbVieLinzess, Armour Thyroid$698$11,75048 claims
PfizerEliquis$61$11,07717 claims
GSKAnoro Ellipta$40$5,25311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 969 nurse practitioner providers in Louisiana.

Other nurse practitioner in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →